| The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes P Rantakari, K Auvinen, N Jäppinen, M Kapraali, J Valtonen, M Karikoski, ... Nature immunology 16 (4), 386-396, 2015 | 187 | 2015 |
| Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury P Rantakari, DA Patten, J Valtonen, M Karikoski, H Gerke, H Dawes, ... Proceedings of the National Academy of Sciences 113 (33), 9298-9303, 2016 | 116 | 2016 |
| Aeroallergen challenge promotes dendritic cell proliferation in the airways TZ Veres, S Voedisch, E Spies, J Valtonen, F Prenzler, A Braun The Journal of Immunology 190 (3), 897-903, 2013 | 25 | 2013 |
| The junctophilin-2 mutation p.(Thr161Lys) is associated with hypertrophic cardiomyopathy using patient-specific iPS cardiomyocytes and demonstrates prolonged action potential … J Valtonen, C Prajapati, RM Cherian, S Vanninen, M Ojala, K Leivo, ... Biomedicines 11 (6), 1558, 2023 | 2 | 2023 |
| Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism A Alexanova, E Raitoharju, J Valtonen, K Aalto-Setälä, LE Viiri Scientific Reports 13 (1), 1706, 2023 | 1 | 2023 |
| Gellan gum-gelatin based cardiac models support formation of cellular networks and functional cardiomyocytes H Vuorenpää, J Valtonen, K Penttinen, S Koskimäki, E Hovinen, A Ahola, ... Cytotechnology, 1-20, 2024 | | 2024 |
| The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential … J Valtonen, C Prajapati, RM Cherian, S Vanninen, M Ojala, K Leivo, ... | | 2023 |
| A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Prolonged Relaxation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Hypertrophic … J Valtonen, K Aalto-Setala Circulation 146 (Suppl_1), A10925-A10925, 2022 | | 2022 |
| miRNA expression of hepatocytes derived from induced pluripotent stem cells of coronary artery disease patients A Alexanova, J Valtonen, L Viiri, M Kiamehr, K Aalto-Setälä Atherosclerosis 331, e220, 2021 | | 2021 |
